Evidence map›Paper›PMID 26716769›Full record

ArticleeLife2015

YcgC represents a new protein deacetylase family in prokaryotes.

Shun Tu, Shu-Juan Guo, Chien-Sheng Chen, Cheng-Xi Liu, He-Wei Jiang, Feng Ge, Jiao-Yu Deng, Yi-Ming Zhou, Daniel M Czajkowsky, Yang Li and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. FMolecular biology reports · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Protein lysine acetylation regulates oral microorganisms.Frontiers in cellular and infection microbiology · 2025
    Review
  8. YkuR functions as a protein deacetylase inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Influence of NMolecules (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Systematic analysis of lysine malonylation inFrontiers in cellular and infection microbiology · 2022
    Article
  17. Review
  18. Review
  19. Protein post-translational modifications in bacteria.Nature reviews. Microbiology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Shun TuShanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Shu-Juan GuoShanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Chien-Sheng ChenGraduate Institute of Systems Biology and Bioinformatics, National Central University, Jhongli, Taiwan.
Cheng-Xi LiuShanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
He-Wei JiangShanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Feng GeKey Laboratory of Algal Biology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, Hubei, China.
Jiao-Yu DengState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Yi-Ming ZhouNational Engineering Research Center for Beijing Biochip Technology, Beijing, China.
Daniel M CzajkowskyBio-ID Center, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Yang LiShanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Bang-Ruo QiShanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Young-Hoon AhnDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, United States.
Philip A ColeDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, United States.
Heng ZhuDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, United States.
Sheng-Ce TaoShanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Jiao Tong University · CNState Key Laboratory of Oncogene and Related Genes · CNChinese Academy of Sciences · CNJohns Hopkins University · USJohns Hopkins Medicine · USNational Central University · TW

Funding

TCP5: ACTIVE SITE LABELING REAGENT FOR ACETYLTRANSFERASESU54RR020839 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BOEKE, JEF D · 2004 to 2011
$27.4M
Monospecific monoclonal antibodies against human transcription factorsU54HG006434 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI BLACKSHAW, SETH, ZHU, HENG · 2011 to 2015
$13.8M
Protein Acylation and Methylation Mechanisms_Administrative SupplementR37GM062437 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COLE, PHILIP A · 2013 to 2022
$4.1M
Mechanisms &Inhibition of Histone AcetyltransferasesR01GM062437 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COLE, PHILIP A · 2001 to 2012
$3.8M
DNA-Binding Activity of Human Transcription FactorsR01GM076102 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ZHU, HENG · 2006 to 2014
$2.6M
Ethanol induced brain injury is decreased by inhibiting TIEG2 mediated cell deathR01AA020103 · NIAAA · UNIVERSITY OF MISSISSIPPI MED CTR · PI WANG, JUNMING · 2011 to 2014
$1.4M
Epigenetics-mediated transcription regulation in mammalsR01GM111514 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI QIAN, JIANG, ZHOU, FENGQUAN · 2014 to 2017
$1.4M
Hepatic Encephalopathy in Alcoholic Cirrhosis: A Systems Biology ApproachR01AA020203 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BAJAJ, JASMOHAN S · 2010 to 2012
$1.0M
NCRR NIH HHS RR020839NCRR NIH HHS U54 RR020839NHGRI NIH HHS U54 HG006434NIAAA NIH HHS R01 AA020103NIAAA NIH HHS R01 AA020203NIGMS NIH HHS GM076102NIGMS NIH HHS GM62437NIGMS NIH HHS R01 GM062437NIGMS NIH HHS R01 GM076102NIGMS NIH HHS R01 GM111514NIGMS NIH HHS R37 GM062437
6 · The paper itself

Abstract

Reversible lysine acetylation is one of the most important protein posttranslational modifications that plays essential roles in both prokaryotes and eukaryotes. However, only a few lysine deacetylases (KDACs) have been identified in prokaryotes, perhaps in part due to their limited sequence homology. Herein, we developed a 'clip-chip' strategy to enable unbiased, activity-based discovery of novel KDACs in the Escherichia coli proteome. In-depth biochemical characterization confirmed that YcgC is a serine hydrolase involving Ser200 as the catalytic nucleophile for lysine deacetylation and does not use NAD(+) or Zn(2+) like other established KDACs. Further, in vivo characterization demonstrated that YcgC regulates transcription by catalyzing deacetylation of Lys52 and Lys62 of a transcriptional repressor RutR. Importantly, YcgC targets a distinct set of substrates from the only known E. coli KDAC CobB. Analysis of YcgC's bacterial homologs confirmed that they also exhibit KDAC activity. YcgC thus represents a novel family of prokaryotic KDACs.

Indexed as

Protein Processing, Post-TranslationalAmidohydrolasesEscherichia coliEscherichia coli ProteinsLysineSubstrate SpecificityTranscription FactorsAmidohydrolasesEscherichia coli ProteinsLysineRutR protein, E coliTranscription FactorsYcgC protein, E colibiochemistryE. coliprotein lysine deacetylaseproteome microarray

Identifiers

PMID26716769
PMCPMC4709262
OpenAlexW2206706636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.